Activation of focal adhesion kinase through an interaction with β4 integrin contributes to tumorigenicity of colon cancer. Issue 12 (30th May 2016)

• Record Type: Journal Article
• Authors: Tai, Yu‐Ling; Lai, I‐Rue; Peng, Yu‐Ju; Ding, Shih‐Torng; Shen, Tang‐Long
• Is Part Of: FEBS letters. Volume 590:Issue 12(2016)
• Page Start: 1826
• Page End: 1837
• Publication Date: 2016-05-30
• Subjects: β4 integrin -- FAK -- human colon cancer; Biochemistry -- Periodicals; Biophysics -- Periodicals; Molecular biology -- Periodicals; Biochimie -- Périodiques; Biochemistry; Biophysics; Molecular biology; Periodicals; 572.05
• DOI: 10.1002/1873-3468.12215
• Languages: English
• ISSNs: 0014-5793

Abstract

Abstract : High expression of either β4 integrin or focal adhesion kinase (FAK) has been reported in human colon cancer. However, it remains unclear how β4 integrin together with FAK contributes to the tumorigenicity of colon cancer. Here, we demonstrate that the co‐overexpression of β4 integrin and FAK positively correlates with advanced stages of human colon cancer. Activated β4 integrin interacts with FAK and subsequently induces FAK phosphorylation at Tyr397. Furthermore, ablation of the β4 integrin/FAK complex and/or FAK activation impair colon cancer cell proliferation, anchorage‐independent growth, and tumorigenicity. Our data indicate that the β4 integrin/FAK complex and subsequent FAK activation are essential regulators during the tumorigenicity of colon cancer, and we suggest an alternative strategy for colon cancer therapy. Abstract :